UNSPSC 51282423: Piperacillin sodium

This classification denotes an extended spectrum penicillin antibiotic with the molecular formula C23H26N5O7S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M98T69Q7HP, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((((4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, (2s-(2alpha,5alpha,6beta(s*)))- but more generally known as piperacillin sodium, which bears US NIH Compound Identifier 43066.

UNSPSC 51282423 Piperacillin sodium is a Commodity code that captures pharmaceutical products procured by state and local health agencies, though the recent opportunities block shows minimal direct activity under this specific code. The two recent records in the source — an Illinois Department of Public Health piggyback pharmaceutical contract for antibiotics (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) and a Seminole County, Florida competitive bid for Naloxone and drug deactivation systems — are tagged to this code despite being distinct products from piperacillin sodium itself. State and local health departments, county health systems, and specialized procurement consortia access pharmaceutical inventories through piggyback arrangements with established vendor contracts and direct competitive bidding processes. The Illinois contract, awarded to Chartwell Rx LLC through the MMCAP Infuse consortium, demonstrates how state health agencies leverage cooperative purchasing vehicles to supply common antibiotic medications on a volume basis, while the Seminole County solicitation reflects emergency-response and community health purchasing patterns unrelated to the code's nominal scope.

Geographic activity under this code draws primarily from the Midwest and Southeast based on the available records. The Illinois Department of Public Health's $2.99 million three-year contract (awarded August 28, 2026) and Seminole County's annual Naloxone procurement (due July 26, 2023, though that date is in the past relative to today's date of October 20, 2026) represent the extent of recent opportunities surfaced. The mismatch between the code's name — piperacillin sodium, a beta-lactam antibiotic — and the actual products being procured (doxycycline, ciprofloxacin, naloxone, drug deactivation systems) suggests the code shows little directly relevant recent activity for piperacillin sourcing. Firms pursuing state and local pharmaceutical distribution should monitor cooperative purchasing consortia like MMCAP Infuse and track individual state health department RFQs and IFBs; the piggyback model and direct-bid pathways dominate the landscape, but the tagged opportunities here do not reflect active piperacillin-specific demand.